13-D Call Re the RTF. In the call last night,
Post# of 148277
In the call last night, the 13D group made very serious accusations regarding the FDA's refusal to file, saying it was because the company mixed up a tropism test with a receptor occupancy test.
If true, this would be a scathing indictment of current management.
If false, this would put the 13D group in a bad light.
The best way to resolve this dispute is for CYDY to release the RTF letter issued by the FDA.